PHP
Parkman Healthcare Partners Portfolio holdings
AUM
$864M
This Quarter Return
+2.96%
1 Year Return
+33.7%
3 Year Return
+258.24%
5 Year Return
+878.92%
10 Year Return
–
AUM
$460M
AUM Growth
+$460M
(+22%)
Cap. Flow
+$103M
Cap. Flow
% of AUM
22.41%
Top 10 Holdings %
Top 10 Hldgs %
34.98%
Holding
99
New
18
Increased
56
Reduced
8
Closed
16
Top Buys
| 1 |
Cooper Companies
COO
|
$15.8M |
| 2 |
Neurocrine Biosciences
NBIX
|
$10.3M |
| 3 |
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
|
$10.2M |
| 4 |
Becton Dickinson
BDX
|
$9.85M |
| 5 |
Zimmer Biomet
ZBH
|
$8.4M |
Top Sells
| 1 |
UnitedHealth
UNH
|
$14.7M |
| 2 |
CNCE
Concert Pharmaceuticals, Inc.
CNCE
|
$7.03M |
| 3 |
Danaher
DHR
|
$5.84M |
| 4 |
Rhythm Pharmaceuticals
RYTM
|
$4.6M |
| 5 |
Sarepta Therapeutics
SRPT
|
$4.58M |
Sector Composition
| 1 | Healthcare | 99.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
United Therapeutics
UTHR
$13.8B
| $24.2M | 5.26% | 108,072 +7,370 | +7% | +$1.65M |
|
|
2
Neurocrine Biosciences
NBIX
$13.8B
| $22M | 4.8% | 217,838 +101,505 | +87% | +$10.3M |
|
3
Boston Scientific
BSX
$156B
| $21.4M | 4.66% | 428,231 +60,298 | +16% | +$3.02M |
|
|
4
Cooper Companies
COO
$13.4B
| $19.6M | 4.25% | 52,384 +42,384 | +424% | +$15.8M |
|
5
Lantheus
LNTH
$3.73B
| $15.5M | 3.36% | 187,187 +96,264 | +106% | +$7.95M |
|
|
SGEN
6
DELISTED
Seagen Inc. Common Stock
SGEN
| $14.8M | 3.22% | 73,100 -8,754 | -11% | -$1.77M |
|
7
Haemonetics
HAE
$2.63B
| $11.6M | 2.53% | 140,740 +8,362 | +6% | +$692K |
|
8
Tenet Healthcare
THC
$16.3B
| $11M | 2.4% | 185,832 +59,327 | +47% | +$3.53M |
|
9
Schrodinger
SDGR
$1.44B
| $10.5M | 2.29% | 399,170 +171,219 | +75% | +$4.51M |
|
|
SWAV
10
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $10.2M | 2.21% | +46,855 | New | +$10.2M |
|
11
Elevance Health
ELV
$71.8B
| $9.95M | 2.16% | 21,643 +9,347 | +76% | +$4.3M |
|
12
Xenon Pharmaceuticals
XENE
$2.98B
| $9.92M | 2.16% | 277,283 +41,792 | +18% | +$1.5M |
|
|
13
Becton Dickinson
BDX
$55.3B
| $9.85M | 2.14% | +39,788 | New | +$9.85M |
|
|
VRNA
14
Verona Pharma
VRNA
$9.16B
| $9.8M | 2.13% | 487,995 +73,547 | +18% | +$1.48M |
|
15
Eli Lilly
LLY
$657B
| $9.5M | 2.07% | 27,671 -6,767 | -20% | -$2.32M |
|
|
SILK
16
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $9.39M | 2.04% | 239,864 +146,559 | +157% | +$5.73M |
|
17
DexCom
DXCM
$29.5B
| $9.17M | 1.99% | 78,927 +16,197 | +26% | +$1.88M |
|
18
Insulet
PODD
$23.9B
| $9.17M | 1.99% | 28,744 +10,702 | +59% | +$3.41M |
|
19
IQVIA
IQV
$32.4B
| $9.08M | 1.97% | 45,643 +30,269 | +197% | +$6.02M |
|
20
Humana
HUM
$36.5B
| $8.66M | 1.88% | 17,837 +398 | +2% | +$193K |
|
|
CDMO
21
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $8.52M | 1.85% | 453,952 +25,684 | +6% | +$482K |
|
|
22
Zimmer Biomet
ZBH
$21B
| $8.4M | 1.83% | +65,000 | New | +$8.4M |
|
23
Keros Therapeutics
KROS
$618M
| $7.66M | 1.67% | 179,290 +52,500 | +41% | +$2.24M |
|
|
DCPH
24
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $7.6M | 1.65% | 491,772 +146,852 | +43% | +$2.27M |
|
|
CTIC
25
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $7.37M | 1.6% | 1,753,630 +344,988 | +24% | +$1.45M |
|